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Background: Management of allergic patients in the population is becoming more difficult 
because of increases in both complexity and prevalence. Although general practitioners (GPs) 
are expected to play an important role in the care of allergic patients, they often feel ill-equipped 
for this task. Therefore, the aim of this study was to develop an allergy management support 
system (AMSS) for primary care.
Methods: Through literature review, interviewing and testing in secondary and primary care 
patients, an allergy history questionnaire was constructed by allergists, dermatologists, GPs 
and researchers based on primary care and specialists’ allergy guidelines and their clinical 
knowledge. Patterns of AMSS questionnaire responses and specific immunoglobulin E (sIgE)-
test outcomes were used to identify diagnostic categories and develop corresponding manage-
ment recommendations. Validity of the AMSS was investigated by comparing specialist (gold 
standard) and AMSS diagnostic categories.
Results: The two-page patient-completed AMSS questionnaire consists of 12 (mainly) mul-
tiple choice questions on symptoms, triggers, severity and medication. Based on the AMSS 
questionnaires and sIgE-test outcome of 118 patients, approximately 150 diagnostic categories 
of allergic rhinitis, asthma, atopic dermatitis, anaphylaxis, food allergy, hymenoptera allergy 
and other allergies were identified, and the corresponding management recommendations were 
formulated. The agreement between the allergy specialists’ assessments and the AMSS was 
69.2% (CI 67.2–71.2).
Conclusion: Using a systematic approach, it was possible to develop an AMSS that allows for 
the formulation of diagnostic and management recommendations for GPs managing allergic 
patients. The AMSS thus holds promise for the improvement of the quality of primary care for 
this increasing group of patients.
Keywords: allergy, development, diagnosis, management support system, primary care
Background
The prevalence of atopic allergies in the population is rising, and patients with aller-
gies constitute a burgeoning problem for health care systems. Recently the European 
Academy for Allergy and Clinical Immunology (EAACI) Task Force for Allergy Man-
agement in Primary Care noted the unsustainability of the current model, in which the 
care for allergic patients is predominantly specialist based.1 The Task Force proposed a 
holistic primary care-based system where primary care should be equipped for caring 
allergic patients by receiving education and support from allergists. In addition, there 
should be clear guidelines for GPs about how to diagnose and manage patients with 
allergic diseases, including referral, when appropriate.1
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In many areas in Europe, only very few allergists are 
available.2 Worldwide, the number of certified allergists per 
head of population ranges from 1:25 million to 1:16,000.3 In 
addition, referred patients usually need to wait >6 weeks for 
a consultation with an allergist.2 Although general practitio-
ners (GPs) are well trained, few have sufficient knowledge of 
diagnosis and management of allergic patients.4,5 Moreover, 
GPs often experience difficulty in arriving at the correct 
diagnosis resulting in inadequate management.6
Although most GPs feel that they are generally able to 
manage patients with common allergies, there are specific 
issues that may need attention. In an earlier study, we found 
that GPs felt inadequately trained to manage food-related, 
insect-related and drug-related allergies as well as unfa-
miliar allergies, especially when anaphylactic reactions 
were involved (Brakel TM, et al, unpublished data, 2017). 
Furthermore, knowledge of skin-related problems was seen 
as suboptimal by the GPs themselves (Brakel TM, et al, 
unpublished data, 2017). In addition, GPs reported prob-
lems with the interpretation of specific immunoglobulin E 
(sIgE)-test results. Problems emerged when the patient’s his-
tory suggested an allergy, but the sIgE-test results were not 
confirmative and conversely when positive sIgE-test results 
were found for allergens with no clinical relevance (Brakel 
TM, et al, unpublished data, 2017). Although GPs feel com-
fortable with handling asthma and rhinitis, there continues to 
be room for improvement, such as the recognition of allergic 
rhinitis7 and the over-diagnosis of allergies (not confirmed by 
allergy specialists).8 In the UK, it has been estimated that a 
quarter and possibly half of allergy referrals to the hospital 
could probably be dealt with by a GP with special interest 
in allergy.9,10 Another issue is the under-prescription of epi-
nephrine auto-injectors, especially, for children at risk for an 
anaphylactic reaction,11,12 which may be at least partly due 
to GPs not prescribing this medication to patients for whom 
it would be appropriate to do so.13
In the past, our group was successfully involved in the 
set-up and implementation of an asthma/COPD diagnostic 
support service, which showed high uptake (11,000 patients 
in 2015) and improved patients’ outcomes.14 In order to 
support GPs with the diagnosis and management of aller-
gic patients, we developed an allergy management support 
system (AMSS). To our knowledge, this is the first allergy 
support system for primary care based on a structured and 
extensive clinical history questionnaire and sIgE-test out-
comes. In the past, only one partly comparable initiative has 
been undertaken by adding standardized sentences to sIgE-
test outcomes.15 Our AMSS aims to help GPs to effectively 
cope with allergic patients in primary care practices. As the 
AMSS may assist GPs to treat more patients in primary care, 
the system subsequently may help to reduce waiting times 
for specialist care by focusing scarce resources on those who 
most need secondary care.
Methods
The development of the AMSS was based on information 
obtained from the literature and from allergy specialists and 
GPs. In addition, semi-structured, in-depth interviews were 
conducted with 12 GPs (with no special interest in allergy), 
in order to obtain necessary information for the development 
of the AMSS that would make it fit for purpose and suitable 
for integration into the daily workflow of the GP (Brakel TM, 
et al, unpublished data, 2017). The research group, consist-
ing of pediatric and adult allergists, dermatologists, GPs and 
allergy researchers, constructed a preliminary allergy history 
questionnaire based on primary care and specialists’ allergy 
guidelines, and their clinical knowledge. This history ques-
tionnaire inquires about patients’ symptoms relating to the 
different allergic disorders. Based on the patient’s responses 
to this questionnaire as well as their sIgE-test outcomes, 
probable diagnoses and corresponding management recom-
mendations are generated by the AMSS (Figure 1).
Figure 1 schematic representation of the allergy management support system 
(AMss).
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Development of the AMss questionnaire
First, the history questionnaire was mock tested by allergy 
specialists and GPs. The allergy researcher completed five 
questionnaires with different hypothetical patients in mind. 
These questionnaires were analyzed by two allergy specialists 
and two GPs, and they individually formulated a diagnosis. 
Inconsistencies between the diagnosis of the researcher and 
the physicians were discussed within the research group. 
Amendments were made to the wording of certain questions 
in the questionnaire when needed.
Next, the history questionnaire was pre-tested in ten 
allergic patients and ten parents of allergic children. These 
subjects were asked to explain the meaning of each question 
in their own words. Based on possible difficulties or misun-
derstandings, further amendments were made to the wording 
of certain questions in the questionnaire. The resultant AMSS 
questionnaire was subject to several constraints: It had to be 
limited to two pages, with short, clear questions and multiple-
choice answers using simple tick boxes.
sige testing by gPs
In order to get more insights into what kind of allergic prob-
lems were seen in primary care as well as the reason for sIgE 
testing by GPs, we aimed at obtaining and analyzing 100 
completed AMSS questionnaires. Primary care patients who 
were sent to the local GP laboratory for one or more sIgE 
tests received the AMSS questionnaire. This questionnaire 
was self-completed at home by patients or their parents. At 
this stage, GPs did not receive recommendations from the 
AMSS, since the system was still under development.
Development of the diagnostic 
classification and management 
recommendations
The diagnostic categories, including disease severity (ie, mild, 
moderate, severe), were based on certain combinations of 
responses given to the AMSS questionnaire items (patterns). 
For each diagnostic category, corresponding management 
recommendations were formulated based on primary care 
and specialists’ allergy guidelines complemented with clini-
cal knowledge and expert opinion. Thus, with these response 
patterns, a rule-based system was developed that captures the 
relevant information from evidence-based medicine as well 
as knowledge of the allergy experts into distinct algorithms.
Agreement between AMss and specialist
In order to validate the AMSS, the AMSS questionnaire was 
completed by patients who were referred by GPs to allergists 
(pediatric or adult) or dermatologists. The GPs who included 
these patients were not involved in this part of the study. 
Patients or their parents completed the questionnaire at home 
before their consultation with the specialist. The completed 
questionnaires were analyzed by two researchers (TMB [post-
doc primary care] and EMR [medical student performing 
internship]) who allocated the patients to predefined diag-
nostic categories using the algorithms of the AMSS. Based 
on the clinical correspondence, two allergists (AEJD and 
RLO) and two dermatologists (MLAS and WAC) allocated 
the same patients to predefined diagnostic categories using 
their clinical knowledge, which was considered to be the gold 
standard (Figure 2). Agreement between the assessment by 
the specialist (gold standard) and the AMSS was investigated 
by ascertaining concordance of diagnostic categories in a 
qualitative and a quantitative way. In the qualitative analysis, 
agreement was categorized based on the diagnosis and degree 
of severity (mild, moderate and severe):
•	 Total agreement: same diagnosis and same severity;
•	 Substantial agreement: same diagnosis, but one severity 
degree apart;
•	 Partial agreement: same diagnosis, but more than one 
severity degree apart;
•	 No agreement: different diagnosis.
The quantitative analysis was restricted to the main aller-
gic diagnostic categories (allergic rhinitis, asthma, atopic 
dermatitis, anaphylaxis, food allergy, hymenoptera allergy, 
latex allergy, work or hobby-related allergy, drug-related 
allergy and urticaria/angioedema), and the degree of  severity 
Figure 2 Flowchart of the validity study on agreement between the allergy specialist 
(gold standard) and the AMss.
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was not taken into account. Only cases were used where 
there was agreement between specialists (gold standard) 
and also between researchers (AMSS). These constraints 
were imposed by the calculation of the agreement score. 
The agreement between the gold standard and AMSS was 
calculated as (TP/TP+FN)×100%, where true positive (TP) 
indicates that both the gold standard and the AMSS reported 
the same diagnosis and false negative (FN) indicates that 
the AMSS missed a diagnosis made by the gold standard. 
The resultant percentage indicates the percentage of correct 
diagnoses from the AMSS. The inter-rater agreement between 
the allergists, dermatologists and researchers was investigated 
using Cohen’s Kappa.
This study was approved by the local medical ethics 
committee of the University Medical Center Groningen 
(METc 2011/273) who deemed that the study did not fall 
within the Medical Research Involving Human Subjects Act. 
Official informed consent from participants was therefore 
not required. Participation was voluntary, and all participants 
received written and/or oral information about the study.
Results
Description of the content of the AMss 
questionnaire
The AMSS questionnaire contains questions relating to the 
different allergic disorders. It includes questions relating to 
the diagnosis as well as disease severity and whether a doc-
tor’s diagnosis has been made. Current medications and their 
effectiveness were documented in order to assess whether 
the medication prescribed was in keeping with the severity 
of the disease. Questions about possible environmental and 
food allergens were included as well as circumstances and 
consequences of exposure, including exposures at work 
(Figure S1).
Allergic (seasonal and perennial) rhino conjunctivitis
Questions included symptom type and severity (based on 
Control of Allergic Rhinitis and Asthma Test),16 presence 
and degree of seasonality, and effect of medication. The 
goal was to identify severity and symptom control with 
pharmacotherapy (including self-reported compliance) as 
well as suitability for immunotherapy with pollen, house 
dust mite or cat.
Asthma
Questions included the type and severity of symptoms and 
secondary impact on daily activities (based on Control 
of Allergic Rhinitis and Asthma Test).16 Medications and 
self-reported compliance were included in the assessment. 
The effect of both allergic and non-allergic triggers was also 
covered.
Atopic dermatitis
Questions addressed the age of onset, distribution of clinical 
signs, family history of atopic disease and the presence of 
a dry skin (based on the United Kingdom Working Party’s 
Diagnostic Criteria for Atopic Dermatitis).17 Additional 
questions addressed the severity of symptoms and recent 
topical treatment. With regard to severity and treatment, 
separate questions were posed about the face and the rest 
of the body.
Anaphylaxis
Symptoms of anaphylaxis were recorded as well as the sus-
pected cause, including foods, drugs, latex, insect stings or 
none of these causes. A question distinguishing local from 
systemic reactions to insect stings was included. Based on 
the type of symptoms that occurred, high-risk patients could 
be distinguished from low-risk patients, and the need for an 
epinephrine auto-injector could be assessed. High-risk food 
allergy was defined when at least one of the following criteria 
was met: 1) previous history of a life-threatening anaphylactic 
reaction to a food; 2) previous asthmatic reaction caused by a 
food; 3) severe (uncontrolled) asthma; 4) any two of the fol-
lowing: a) aged >12 years; b) coexistent asthma; c) suspected 
allergy to peanut, nuts, sesame, crustaceans or fish; and d) 
previous clear systemic reaction to traces of food (derived 
from the EAACI guideline for anaphylaxis).18
Food allergy
Apart from the suspected food, circumstances surrounding 
ingestions resulting in reactions were documented, including 
the time between ingestion and reaction, estimated quantity 
ingested and duration of symptoms. The effect on symptoms 
of dietary elimination of the allergenic food was recorded. 
A separate question addressed tolerance to milk products 
other than milk itself in patients with suspected allergy to 
cow’s milk.
sige testing by gPs
In total, 118 primary care patients completed the AMSS 
questionnaire. The mean age was 31.7 years (range from 
12 months to 81 years), and 40% was male. The following 
were indications for sIgE testing in these patients: rhinitis 
(51%), asthma (26%), eczema (15%), food allergy (9%), 
anaphylaxis (1%) and others (18%). The questionnaire 
appeared to be user-friendly since the vast majority of the 
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Description of the diagnostic 
classification and management advice
The combination of the patient’s responses to the AMSS ques-
tionnaire with the sIgE-test outcomes allowed for allocation 
of patients to distinct diagnostic categories. Each diagnostic 
category was coupled to a management recommendation. In 
total, there are currently approximately 150 different catego-
ries of allergic rhinitis, asthma, atopic dermatitis, anaphy-
laxis, food allergy, hymenoptera allergy and other allergies 
(latex allergy, work-related allergy, drug-related allergy and 
urticaria). These categories were based on the type of allergy, 
severity and treatment status. Also, non-allergic categories 
were defined (eg, “non allergic rhinitis” and “unlikely food 
allergy”). The management recommendations were usu-
ally structured as an initial therapeutic option, followed by 
subsequent management steps to be followed if the initial 
treatment did not have the desired effect. The management 
recommendations could also include non-therapeutic recom-
mendations and referral recommendations (Box 1). Back-
ground information accompanying the recommendations 
was provided to the GP as an appendix. This information 
was specifically formulated for the AMSS.
Agreement between AMss and specialist
The AMSS questionnaire was completed by 42 patients or their 
parents who had been referred by GPs to allergists (pediatric or 
adult) or dermatologists. The majority of patients were female 
(62%) with a mean age of 26 years (range from 2 months to 68 
years). The mean time between completing the questionnaire 
and the consult was 8 days (SD 11 days). About half of them 
consulted the allergist (n=20) and the others consulted the pedi-
atric allergist (n=11) or dermatologist (n=11). The qualitative 
agreement (sum of total, substantial and partial agreement) 
between the specialists (gold standard) and the researchers 
(AMSS) ranged between 54% and 87%. The quantitative 
agreement between the gold standard and the AMSS was 69% 
(CI 67–71). This indicates the percentage of correct diagnoses 
made by the AMSS. The inter-rater agreement between the 
two allergists was moderate (k=0.55, CI 0.37–0.72), as was 
the inter-rater agreement between the two dermatologists 
(k=0.53, CI 0.14–0.91). The inter-rater agreement between the 
two researchers was high (k=0.98, CI 0.94–1.01).
Discussion
Main findings
The AMSS presented here is the first support system for 
allergy management in primary care and may be a useful tool 
for GPs, allowing them to provide quality care for allergic 
patients. It covers a wide variety of allergic diseases, and 
yet only comprises a two-page questionnaire and sIgE-test 
results. There was good agreement between the AMSS and 
specialist recommendations (gold standard), supporting the 
validity of the AMSS.
Interpretation of the findings in relation 
to previously published work
The AMSS was inspired by the Asthma COPD service (AC-
service),14 which allows GPs to refer patients with possible 
obstructive airway disease to the AC-service. Patients com-
plete a history questionnaire, and spirometry is performed at 
the GP laboratory. Pulmonologists assess these patient data 
through an online secured internet portal and send a diagno-
sis and management recommendation to the GP. Currently, 
11,000 patients have been assessed by the AC-service, and 
it is considered to be feasible and effective.14 Comparable 
outcomes may be expected for the AMSS when it is imple-
mented in a broader fashion. However, an important difference 
between the AMSS and the Asthma COPD service is that 
specialists involved in the AC-service assess all patient infor-
mation individually, whereas in the AMSS patient information 
assessment will ultimately be automated as much as possible.
An important aspect of the functioning of the AMSS is 
that it will probably have a learning effect. GPs are likely to 
become more effective in diagnosing, managing and referring 
Box 1 example of AMss recommendations for a gP.
AMss advice
Probable diagnosis:
1. severe seasonal rhinitis symptoms, not adequately treated.
2. Moderate allergic asthma symptoms, not adequately treated.
3.  non-life-threatening food allergic reaction, systemic, more than 
only oral allergy syndrome: low-risk food allergy.
recommendations for the above-mentioned probable diagnosis:
1. •  if possible, avoid nonspecific triggers that cause symptoms;
   •  start a non-sedating antihistamine (step 1);
   •  start an intranasal corticosteroid (step 2);
   •  consider the addition of an intra-ocular antihistamine, if eye 
symptoms are prominent;
   •  after instituting above pharmacotherapy, consider (referral 
for) immunotherapy.
2. •  avoid nonspecific triggers that cause symptoms (step 1);
   •  avoid exposure to smoke;
   •  continue bronchodilator when needed plus inhaled 
corticosteroid use two times a day;
   •  check proper use of medication;
   •  add LABA or combined preparation (corticosteroid plus 
lABA) (step 2).
3. •  Consider short-term elimination of the culprit food, 
preferably with the aid of a nutritionist.
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allergic patients9 when working with the recommendations of 
the AMSS. GPs will probably develop a better understanding 
of whether sIgE determinations are required and how they 
should be interpreted. This direct patient-related learning 
might be one of the benefits of the AMSS and may, in gen-
eral, improve care for patients with allergies.19 This aspect 
of the AMSS is important because it is well recognized that 
knowledge of guidelines is generally poor, and that such 
guidelines are generally not followed.20,21
A further possible advantage of the AMSS may be that it 
does not just focus on the patient’s main reason for seeking 
consultation. Because of the comprehensive nature of the 
AMSS questionnaire, it could also address comorbid allergic 
disorders. This is particularly relevant in primary care where 
GPs are often limited to a single medical problem because 
of time constraints, while multiple atopic conditions are 
frequently present in the same patient.22
Finally, it should be noted that the AMSS questionnaire 
is not intended to replace a specialist consultation but rather 
to support GPs in diagnosing and managing patients with 
allergic symptoms. The AMSS generates recommendations 
based on the answers on the AMSS questionnaire and the 
sIgE-test results. The AMSS recommendations empower 
the GP to manage many patients with allergic symptoms in 
primary care, thus avoiding unnecessary referrals. In complex 
or high-risk cases, the AMSS advises the GP to refer the 
patient to a specialist. Ultimately, GPs remain responsible 
and autonomous, and are free to deviate from the recom-
mendations of the AMSS.
Although previous studies (Brakel TM, et al, unpublished 
data, 2017)6 show that GPs felt more comfortable managing 
patients with airway allergy (ie, asthma and rhinitis) than 
those with systemic allergy (ie, food allergy and anaphylaxis), 
we found that sIgE tests were often requested for both the 
types of allergy. Therefore, the AMSS includes information 
on the proper interpretation of sIgE-test results for both 
airway allergy and systemic allergy.
strengths and limitations of this study
A strength of this study is the comprehensive approach to 
develop the AMSS and its content. Multiple steps and differ-
ent approaches were used to develop and fine-tune the AMSS 
questionnaire and the resultant diagnostic classification and 
management advice. A limitation of this study at this point 
in time is the number of patients who completed the AMSS 
questionnaire in relation to the different diagnostic categories. 
However, many patients have comorbid allergic disorders, 
resulting in more diagnostic categories than patients. Thus, 
most diagnostic categories are covered by patients, and this 
may be considered sufficient to proceed with further utiliza-
tion of the AMSS.
Conclusion
This is the first allergy management support system designed 
for use in primary care. We showed that it was possible to 
develop an AMSS that allows for the formulation of diag-
nostic and management recommendations for GPs manag-
ing allergic patients. Our results support the validity of this 
AMSS. The AMSS thus holds the promise for improvement 
of the quality of primary care for allergic patients.
Recommendations
In the future, the AMSS will be computerized and further 
tested and validated in the primary care setting. In an auto-
mated form, the AMSS can be run efficiently within existing 
systems, allowing GPs to provide up-to-date high-quality 
management23 and may improve selection of patients for 
specialist referral.
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Flokstra - de Blok et al
Supplementary material
Patient name… Name of general practitioner…
Date of birth of the patient… Sex of patient:	male/female
Date of completion… Social security number…
1. What is the reason for this allergy investigation according to you?…
2.  On average, how often do you have the following symptoms during the period of the year during which you are most severely 
affected?
•	 Never/sometimes/1 or 2 days a week/more than 2 days a week/(almost) every day
 2.1 Blocked nose
 2.2 Sneezing/itchy nose
 2.3 Itchy and/or tearing eyes
 2.4 Runny nose
 2.5 Shortness of breath/dyspnea
 2.6 Coughing
 2.7 Wheezing in the chest
 2.8 Chest tightness upon physical exercise
 2.9 Limitations in doing daily tasks because of
   Nasal symptoms
   Chest symptoms
 2.10 Waking up during the night because of
   Nasal symptoms
   Chest symptoms
   Other, namely…
 2.11  During the period of the year during which you are most severely affected, how often did you have to increase your 
medications because of nasal symptoms and/or asthma?
	 	 •	 Never/sometimes/daily
 2.12 Outside the period of the year during which you are most severely affected the symptoms are
	 	 •	 The	same/less	severe/much	less	severe/absent
3. Which of the following is present in your home?
	 	 •	 Cat/dog/bird/rodent/mold/textile	floor	covering	in	bedroom
 4.1 Has a doctor ever diagnosed one or more of the following?
	 	 •	 Asthma/hay	fever/eczema/food	allergy/other	allergy/I	do	not	know/not	diagnosed
 4.2 From which of the aforementioned disease(s) do you have currently symptoms?
	 	 •	 Asthma/hay	fever/eczema/food	allergy/other	allergy/I	do	not	know
5. Last year, did you have an itchy skin disease?
 •	 Yes, go to question 5.1, 5.2, 5.3, 5.4, and 6. No, skip question 5.1, 5.2, 5.3, 5.4, and 6.
	 5.1	 At	which	age	did	this	skin	disease	start?
	 	 •	 Before	the	2nd	year/2–4	years/5–10	years/later
 5.2  Has this skin disease ever been present in the inside of the elbows, back of the knees, front of ankles, neck or around 
the eyes?
  •	 Yes/no/I do not know
 5.3 Last year, did you generally have dry skin?
  •	 Yes/no/I do not know
 5.4 Do one of your parents, brother or sisters have hay fever, asthma or eczema?
  •	 Yes/no/I do not know
6. Complete question 6.1 and 6.2 if you have eczema
 6.1 How severe was the eczema last week?
  •	 Face >	not/mild/moderate/severe/very severe
  •	 Body >	not/mild/moderate/severe/very severe
  How burdensome was the eczema last week?
  •	 Face >	not/a little/moderately/much/very much
  •	 Body >	not/a little/moderately/much/very much
 6.2 Last week, which ointments/creams have been used for eczema and how often?
  On the face;…
  On the body;…
7. Do you have allergic symptoms when you come into contact with:
 •	 Food(s)/wasp and/or honeybee sting/medication/latex/unknown/no  go to question 8
 7.1 If symptoms occur, which symptoms are they? (multiple answers possible)
  •	 	 Dizziness and/or palpitations; unconsciousness; wheezing and/or dyspnea; feeling of throat tightening; vomiting 
and/or diarrhea; nausea and/or stomach cramps; swollen tongue and/or lips; nasal symptoms; itchy mouth, ears 
and/or throat; itchy tongue and/or lips; itchy and/or tearing eyes; worsening eczema (one spot/many spots/all over 
body); itchy skin (one spot/many spots/all over body); red rash (one spot/many spots/all over body); swelling of the 
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Development of allergy management support system
 7.2 In case of wasp and/or honeybee sting, where do the aforementioned skin symptoms occur?
	 	 •	 At	the	place	of	sting/elsewhere
 8.1 During the last 3 months, did you have hives?
	 	 •	 Yes,	some/yes,	quite	a	few/yes,	a	lot/no
 8.2 During the last 3 months, how often did you have hives?
  •	 Daily/weekly/monthly/not at all
9.	 Are	the	allergic	symptoms	possibly	related	to	your	work	or	hobby?
	 	 •	 Yes/no/I	do	not	know
10. Please indicate when or which trigger causes allergic symptoms (multiple answers possible)
  •	 	 Spring/summer/fall/winter/exercise/fog/cold air/cigarette smoke/paint fumes/perfume fumes/cooking fumes/
grasses/trees/dog/cat/horse/(house) dust/weeds/cow’s milk*/egg/soy (milk)/apple/sesame/peanut/almond/walnut/
cashew/hazelnut/pistachio	nut/fish	(1	or	more	species)/shell	fish	(1	or	more	species)/latex	and	or	natural	rubber/
medicine/wasp/honeybee venom/I do not know/other, namely…..
    *In case of cow’s milk, can you eat one of the following  products without symptoms; cheese, Biogarde®, yogurt, 
custard, Danoontje® and/or goat’s milk?
  •	 Yes/no/I do not know
11. Do symptoms occur upon eating certain foods?
 •	 Yes/no (go to question 12)
 11.1 If symptoms occur upon eating certain foods, please indicate how quickly they occur?
  •	 After	a	few	minutes	to	an	hour/after	a	few	hours/after	a	day	or	longer/I	do	not	know
  If symptoms occur upon eating certain foods, please indicate the amount that causes them?
  •	 Traces/crumbs	to	a	few	bites	or	swallows/daily	serving	to	more	than	a	daily	serving/I	do	not	know
  If symptoms occur upon eating certain foods, please indicate how long they persist?
  •	 A	couple	of	hours/a	day	or	longer/a	week	or	longer/I	do	not	know
 11.2 When there is no exposure to the food that (possibly) causes the symptoms, are there…..?
  •	 No allergic symptom/I do not know/sometimes there are allergic symptoms, namely….
12. Do you use medications for your allergic symptoms or asthma (including over the counter medications)?






How well does it work?
 •	 It does not work/inadequate effect/adequate effect/very adequate effect
Please	check	whether	all	applicable	questions	are	completed.	Thank	you	very	much!
Figure S1 content of the provisional version of the allergy management support system questionnaire.
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